Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Feb 12;33(2):218-234.e12.
doi: 10.1016/j.chom.2025.01.002.

A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules

Affiliations
Meta-Analysis

A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules

Moamen M Elmassry et al. Cell Host Microbe. .

Abstract

Gut microbiome changes have been associated with several human diseases, but the molecular and functional details underlying these associations remain largely unknown. Here, we performed a meta-analysis of small molecule biosynthetic gene clusters (BGCs) in metagenomic samples of the gut microbiome from inflammatory bowel disease (IBD) patients and matched healthy subjects and identified two Clostridia-derived BGCs that are significantly associated with Crohn's disease (CD), a main IBD type. Using synthetic biology, we discovered and solved the structures of six fatty acid amides as the products of the CD-enriched BGCs, which we subsequently detected in fecal samples from IBD patients. Finally, we show that the discovered molecules disrupt gut permeability and exacerbate disease in chemically or genetically susceptible mouse models of colitis. These findings suggest that microbiome-derived small molecules may play a role in the etiology of IBD and represent a generalizable approach for discovering molecular mediators of disease-relevant microbiome-host interactions.

Keywords: biosynthetic gene clusters; colitis; fatty acid amides; human microbiome; inflammatory bowel disease; meta-analysis; microbiome-derived small molecules.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.S.D. is a scientific co-founder and CSO at Pragma Biosciences.

Update of

References

    1. Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, et al. (2019). Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662. 10.1038/s41586-019-1237-9. - DOI - PMC - PubMed
    1. Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, et al. (2019). Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med 25, 968–976. 10.1038/s41591-019-0458-7. - DOI - PubMed
    1. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, Nielsen J, and Backhed F. (2013). Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103. 10.1038/nature12198. - DOI - PubMed
    1. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, and Gordon JI (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031. 10.1038/nature05414. - DOI - PubMed
    1. Zhang Y, Bhosle A, Bae S, McIver LJ, Pishchany G, Accorsi EK, Thompson KN, Arze C, Wang Y, Subramanian A, et al. (2022). Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature 606, 754–760. 10.1038/s41586-022-04648-7. - DOI - PMC - PubMed

Publication types

LinkOut - more resources